{"id":"W4402050123","doi":"10.1093/eurheartj/ehae613","title":"Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Astellas Pharma; European Commission; Sanofi; Bayer HealthCare; McMaster University; Gilead Sciences; Novo Nordisk; Steno Diabetes Center Copenhagen; Intas Pharmaceuticals; Eli Lilly and Company; AstraZeneca; Bayer; Pfizer","keywords":"Semaglutide; Medicine; Type 2 diabetes; Kidney disease; Diabetes mellitus; Internal medicine; Disease; Cardiology; Intensive care medicine; Endocrinology; Liraglutide","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002189065,0.000761599,0.001532998,0.0002772982,0.0002332757,0.0008170031,0.0003867451,0.0009078493,0.001869683],"category_scores_gemma":[0.00215397,0.0002139985,0.001704687,0.0003050303,0.0003289842,0.0004721383,0.0003177744,0.001318941,0.000195339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003447621,"about_ca_system_score_gemma":0.0005034056,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001065419,"about_ca_topic_score_gemma":0.001634071,"domain_scores_codex":[0.9993107,0.0004118634,0.00004197369,0.00009872614,0.00006327101,0.00007345217],"domain_scores_gemma":[0.9992024,0.0002555653,0.0002613576,0.00005473412,0.00004983969,0.0001761064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8945638,0.002869697,0.04539242,0.001468813,0.006218777,0.0000981117,0.0000870969,0.001483738,0.001552408,0.0005178216,0.005827461,0.03991996],"study_design_scores_gemma":[0.8273938,0.03784528,0.1160612,0.0004940734,0.01013379,0.0001975657,0.00007197603,0.002999761,0.0007424546,0.001176027,0.002825638,0.00005846851],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846649,0.009687658,0.0003519705,0.0009045788,0.0003017689,0.0003800725,0.001619955,0.00005626417,0.00203292],"genre_scores_gemma":[0.989869,0.002980774,0.0008807892,0.001166649,0.0006517838,0.001008091,0.002161475,0.00001197645,0.001269318],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002189065,"threshold_uncertainty_score":0.01157707,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01714606731619368,"score_gpt":0.2567611198266074,"score_spread":0.2396150525104137,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}